Advertisement

Author: Francesca Mathewes

In July, the FDA approved a new blood test for colorectal cancer screenings that was able to detect 83% of Stage 1, 2 or 3 colorectal cancers in studies. 

ASC leaders and physicians remain frustrated with Medicare and private payers over disparities in reimbursements between their facilities and hospital outpatient departments. 

Advertisement

Certificate-of-need laws have long been a point of contention in ASC development. Here are three recent fights over CON approval:

Miami-based Gastro Health, one of the largest gastroenterology-focused ASC chains in the U.S., opened a new facility in Cincinnati. 

Optum and Tenet are the parent companies of the two largest ASC networks –– SCA Health and United Surgical Partners International, respectively. Here's how the ASC giants stack up against one another right now:

Advertisement